Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Gross Profit (2016 - 2025)

Fortress Biotech has reported Gross Profit over the past 11 years, most recently at $12.6 million for Q4 2025.

  • Quarterly results put Gross Profit at $12.6 million for Q4 2025, up 60.13% from a year ago — trailing twelve months through Dec 2025 was $44.3 million (up 29.47% YoY), and the annual figure for FY2025 was $42.3 million, up 23.6%.
  • Gross Profit for Q4 2025 was $12.6 million at Fortress Biotech, up from $11.9 million in the prior quarter.
  • Over the last five years, Gross Profit for FBIO hit a ceiling of $37.9 million in Q4 2023 and a floor of -$7.6 million in Q2 2023.
  • Median Gross Profit over the past 5 years was $8.2 million (2021), compared with a mean of $7.6 million.
  • Biggest five-year swings in Gross Profit: tumbled 192.02% in 2022 and later soared 614.82% in 2023.
  • Fortress Biotech's Gross Profit stood at $8.0 million in 2021, then tumbled by 192.02% to -$7.4 million in 2022, then soared by 614.82% to $37.9 million in 2023, then plummeted by 79.14% to $7.9 million in 2024, then skyrocketed by 60.13% to $12.6 million in 2025.
  • The last three reported values for Gross Profit were $12.6 million (Q4 2025), $11.9 million (Q3 2025), and $11.5 million (Q2 2025) per Business Quant data.